Randall Leslie Plant, MD - Medicare Otolaryngology in Anchorage, AK

Randall Leslie Plant, MD is a medicare enrolled "Otolaryngology" physician in Anchorage, Alaska. His current practice location is 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, Alaska. You can reach out to his office (for appointments etc.) via phone at (907) 729-3971.

Randall Leslie Plant is licensed to practice in Alaska (license number 4893) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1225063993.

Contact Information

Randall Leslie Plant, MD
4315 Diplomacy Dr, Attn: Sherry Reedy,
Anchorage, AK 99508-5926
(907) 729-3971
(907) 729-1542



Physician's Profile

Full NameRandall Leslie Plant
GenderMale
SpecialityOtolaryngology
Location4315 Diplomacy Dr, Anchorage, Alaska
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1225063993
  • Provider Enumeration Date: 07/11/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 0042254088
  • Enrollment ID: I20050610000658

Medical Identifiers

Medical identifiers for Randall Leslie Plant such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225063993NPI-NPPES
MD4759MedicaidAK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 4893 (Alaska)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Randall Leslie Plant allows following entities to bill medicare on his behalf.
Entity NameAlaska Native Tribal Health Consortium
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437189339
PECOS PAC ID: 6709780265
Enrollment ID: O20031125000772

News Archive

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 3 trial of ponatinib, its investigational pan-BCR-ABL inhibitor, in adult patients with newly diagnosed chronic myeloid leukemia (CML).

Type 2 diabetes is preventable, call for governments to act

The diabetes pandemic is threatening to overwhelm global healthcare services.

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

Experts warn doctors to be aware of new requirements in health bill's false claims act

"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).

Next-generation sequencing assay shows accuracy, sensitivity in detecting genetic mutations in tumors

One of the most promising areas of cancer research is personalized therapy using precision medicine. The National Cancer Institute's NCI-MATCH is a large, ongoing clinical trial that matches tumors to therapies based on the tumor's genetic characteristics.

Read more Medical News

› Verified 9 days ago

Entity NameYukon-kuskokwim Health Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447477815
PECOS PAC ID: 5193718765
Enrollment ID: O20040407001515

News Archive

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 3 trial of ponatinib, its investigational pan-BCR-ABL inhibitor, in adult patients with newly diagnosed chronic myeloid leukemia (CML).

Type 2 diabetes is preventable, call for governments to act

The diabetes pandemic is threatening to overwhelm global healthcare services.

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

Experts warn doctors to be aware of new requirements in health bill's false claims act

"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).

Next-generation sequencing assay shows accuracy, sensitivity in detecting genetic mutations in tumors

One of the most promising areas of cancer research is personalized therapy using precision medicine. The National Cancer Institute's NCI-MATCH is a large, ongoing clinical trial that matches tumors to therapies based on the tumor's genetic characteristics.

Read more Medical News

› Verified 9 days ago

Entity NameTanana Chiefs Conference
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821201278
PECOS PAC ID: 9537050109
Enrollment ID: O20050111000954

News Archive

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 3 trial of ponatinib, its investigational pan-BCR-ABL inhibitor, in adult patients with newly diagnosed chronic myeloid leukemia (CML).

Type 2 diabetes is preventable, call for governments to act

The diabetes pandemic is threatening to overwhelm global healthcare services.

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

Experts warn doctors to be aware of new requirements in health bill's false claims act

"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).

Next-generation sequencing assay shows accuracy, sensitivity in detecting genetic mutations in tumors

One of the most promising areas of cancer research is personalized therapy using precision medicine. The National Cancer Institute's NCI-MATCH is a large, ongoing clinical trial that matches tumors to therapies based on the tumor's genetic characteristics.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Randall Leslie Plant is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Randall Leslie Plant, MD
4315 Diplomacy Dr, Attn: Sherry Reedy,
Anchorage, AK 99508-5926

Ph: (907) 729-3971
Randall Leslie Plant, MD
4315 Diplomacy Dr, Attn: Sherry Reedy,
Anchorage, AK 99508-5926

Ph: (907) 729-3971

News Archive

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 3 trial of ponatinib, its investigational pan-BCR-ABL inhibitor, in adult patients with newly diagnosed chronic myeloid leukemia (CML).

Type 2 diabetes is preventable, call for governments to act

The diabetes pandemic is threatening to overwhelm global healthcare services.

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

Experts warn doctors to be aware of new requirements in health bill's false claims act

"A longtime Miami-Dade healthcare operator and his son have been charged with bilking more than $2.8 million from Medicare in an undercover FBI case. The father has fled the country and the son is cooperating with authorities. Ernesto Angel Montaner and his son, Ernesto Montaner, are accused of operating a network of physical rehabilitation clinics in Miami-Dade that submitted millions of dollars in phony bills to the federal healthcare program for the elderly and disabled between 2003 and 2008" (Weaver, 4/24).

Next-generation sequencing assay shows accuracy, sensitivity in detecting genetic mutations in tumors

One of the most promising areas of cancer research is personalized therapy using precision medicine. The National Cancer Institute's NCI-MATCH is a large, ongoing clinical trial that matches tumors to therapies based on the tumor's genetic characteristics.

Read more News

› Verified 9 days ago


Otolaryngology Doctors in Anchorage, AK

Dr. Jamie Swartz, DO
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 673 Mdg/sghq, 5955 Zeamer Ave, Anchorage, AK 99506
Phone: 907-580-1035    
Christopher Edward Kowalski, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3841 Piper St., Suite T-230, Anchorage, AK 99508
Phone: 907-279-8800    Fax: 907-279-8810
Dr. Mark B. Lorenz, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3730 Rhone Cir Ste 203, Anchorage, AK 99508
Phone: 907-563-3515    Fax: 907-563-3541
Dr. Laura Louise Shively, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508
Phone: 907-729-1400    
Jack Arlyn Smith, M.D.
Otolaryngology
Medicare: Not Enrolled in Medicare
Practice Location: 4001 Dale St, #201, Anchorage, AK 99508
Phone: 907-561-1185    
Dr. James E Kallman, MD
Otolaryngology
Medicare: Not Enrolled in Medicare
Practice Location: 3841 Piper St, Suite T230, Anchorage, AK 99508
Phone: 907-279-8800    Fax: 907-279-8810

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.